| Excerpt | Reference |
|---|
| "55 patients with treated hyperthyroidism (thyreostatics) underwent a T3 suppression test and a TRH stimulation test." | ( Gauer, J; Gottschild, D; Heberling, HJ; Heilmann, W; Löbe, J; Müller, G, 1977) |
| "The major drawback to treatment of hyperthyroidism with antithyroid compounds is the reported low rate of remission." | ( Burrows, BA; Slingerland, DW, 1979) |
| "Serial studies to follow the effects of treatment of hyperthyroidism on red cell membrane ATPase were performed repeatedly in one of these patients." | ( Cole, CH; Waddell, RW, 1976) |
| "The values of successfully treated hyperthyroid patients were normal and those of the treated hypothyroid patients below normal." | ( Cuttelod, S; Holm, AC; Lemarchand-Béraud, T; Scazziga, BR, 1975) |
| "The possibilities of the treatment of hyperthyroidism are mentioned, in which cases the author especially deals with the medicamentous therapy, taking into consideration the different chemical groups (imidazol derivations, thiourazil derivations, perchlorates) and their therapeutic mechanisms." | ( Gauer, J; Heberling, HJ; Lohmann, D, 1976) |
| "However, in patients treated for hyperthyroidism a hyper-response to glucagon can continue after blood levels of thyroid hormones are reduced to normal." | ( Madsen, SN, 1977) |
| "In untreated hyperthyroid subjects, both plasma cyclic AMP and cyclic GMP levels were significantly elevated above normal with mean values of 35." | ( Lin, T, 1979) |
| "Lymphocytes from 12 patients with untreated hyperthyroidism were compared to lymphocytes from age- and sex-matched euthyroid control subjects to test the hypothesis that alterations in beta-adrenergic response mechanisms occur in human hyperthyroidism." | ( Guthrow, CE; Lefkowitz, RJ; Williams, RS, 1979) |
| "In this work treatment for hyperthyroid patients is described; 350 mg were administered daily in divided doses, every two and eight hours." | ( Bonilla-Lajud, I; Callejas-Ramos, F; Escobar-Cauz, G; Gutiérrez-Perez, HM; Mendoza-Morfin, F; Ortigosa-Ramírez, JL; Oseguera-Valladares, R, 1979) |
| "A group of 96 patients suffering from untreated hyperthyroidism (85 women and 11 men) was studied (79 of these patients were also followed during treatment) and compared to a control group of 157 persons (107 women and 50 men)." | ( Friis, T; Linde, J, 1979) |
| "Following treatment of the hyperthyroid group for 1-2 weeks there was a significant decrease in serum triiodothyronine (T3) which correlated with the plasma propranolol steady state concentration." | ( Crooks, J; Feely, J; Isles, TE; Ratcliffe, WA, 1979) |
| "In untreated hyperthyroidism a significant decrease was found in both BMC and BMC'." | ( Charles, P; Mosekilde, L; Nielsen, HE, 1979) |
| "After treatment of hyperthyroidism the MCV rose in these patients by an average of 6 fl." | ( Himsworth, RL; Nightingale, S; Vitek, PJ, 1978) |
| "Finally, iodides do have a role in the treatment of hyperthyroidism but their use should probably be restricted to thyroid storm, preoperative preparation of the hyperthyroid patient, and following 131I treatment." | ( Braverman, LE; Vagenakis, AG, 1975) |
| "We described the effect of untreated hyperthyroidism on Na+K+ATPase activity, ouabain binding sites and intracellular sodium concentration." | ( Chen, S; De Riva, C; Frigato, F; Virgili, F, 1992) |
| "Improved values were seen after treatment for hyperthyroidism although statistical significance was not reached." | ( Behera, D; Dash, RJ; Jindal, SK; Roy, R, 1992) |
| "After treatment of hyperthyroidism, serum EGF returned to the normal levels (232 +/- 176 pmol/l)." | ( Hui, WM; Kung, AW; Ng, ES, 1992) |
| "In the patients with untreated hyperthyroidism, t1/2t was significantly reduced (22." | ( Iversen, E, 1991) |
| "Patients included 42 adults with untreated hyperthyroidism (FT4 greater than 25 pmol/l; TSH less than 0." | ( Amit, T; Hertz, P; Hochberg, Z; Ish-Shalom, S; Lotan, R; Luboshitzki, R; Youdim, MB, 1991) |
| "Similar effects were observed after T4-treatment, but hyperthyroidism induced disproportionate increases in energy expenditure (+7%), plasma glycerol (+310%), and ketone body levels (+436%)." | ( Acheson, KJ; Burger, AG; Jequier, E; Müller, MJ, 1990) |
| "Early detection and treatment of feline hyperthyroidism presents an obvious advantage in avoiding some of the deleterious effects of chronic thyroid hormone excess (eg, cardiomyopathy)." | ( Graves, TK; Peterson, ME, 1990) |
| "After the treatment of 17 hyperthyroid patients with antithyroid drugs, both mean plasma T4 and T3 levels became normal within 4 weeks, but the normalization of RBC Zn lagged about 2 months behind them." | ( Itagaki, Y; Kaise, K; Kaise, N; Kiso, Y; Sakurada, T; Watanabe, TK; Yamamoto, M; Yoshida, K; Yoshinaga, K, 1990) |
| "Data of 196 patients treated for hyperthyroidism exclusively with antithyroid drugs were analyzed retrospectively concerning the relapse rate within a follow-up period of four years." | ( Dickmann, N; Emrich, D; Schicha, H; Voth, E, 1990) |
| "After treatment of hyperthyroidism, the neurological symptoms disappeared." | ( Corominas Torres, JM; Lloreta Trull, J; Oliva Bielsa, J; Pou Serradell, A; Roquer Gonzalez, J; Ugarte Elola, A, 1990) |
| "After successful treatment of hyperthyroidism, SHBG levels normalized in patients with nIST, but they did not change in patients with nnIST." | ( Beck-Peccoz, P; Brabant, G; Faglia, G; Forloni, F; Marcocci, C; Mariotti, S; Medri, G; Pinchera, A; Roncoroni, R, 1990) |
| "The mean [Na+]i value in the untreated hyperthyroidism group was significantly higher than that in the normal subjects (p less than ." | ( Bang, BK; Cha, BY; Hong, KS; Kang, SK; Kim, YW; Lee, KW; Moon, HR; Son, HY; Yoon, YS, 1989) |
| "In the untreated hyperthyroid group, the serum levels of total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol (LDL-C) were significantly decreased compared to the controls and increased after treatment." | ( Oribe, H, 1989) |
| "With appropriate treatment of hyperthyroidism and hypothyroidism, the levels of the three peptides returned to normal." | ( Sallman, AL; Vesely, DL; Winters, CJ, 1989) |
| "ANP values of untreated hyperthyroid patients varied greatly from patient to patient, but decreased progressively with a decrease of serum thyroid hormone concentration during methimazole treatment." | ( Aizawa, T; Ishihara, M; Iwasaki, T; Sato, A; Shigematsu, S; Shinoda, T; Takemura, Y; Yamada, T, 1989) |
| "Fasting C-peptide was reduced in untreated hyperthyroidism (0." | ( Beer, SF; Hales, CN; Parr, JH; Temple, RC, 1989) |
| "We studied the effects of radioiodine treatment of hyperthyroidism due to Graves' disease on Graves' ophthalmopathy and the possible protective role of corticosteroids." | ( Bartalena, L; Bogazzi, F; Lepri, A; Marcocci, C; Panicucci, M; Pinchera, A, 1989) |
| "In the pretreatment biopsy (hyperthyroid state), there was a significantly lower proportion of type I fibres (30% vs." | ( Blomstrand, E; Celsing, F; Clausen, N; Jansson, E; Lins, PE; Melichna, J; Terrados, N, 1986) |
| "It recovered after treatment of hyperthyroidism." | ( Erfurth, EM; Hedner, P, 1988) |
| "Symptoms generally cease after treatment of the hyperthyroidism." | ( Stoffer, SS, 1988) |
| "Levels of TBAR in untreated hyperthyroid patients in plasma (16." | ( Sir, T; Videla, LA; Wolff, C, 1988) |
| "However, a comparison of untreated hyperthyroid with untreated hypothyroid patients showed a highly significant difference in EGF excretion (P less than 0." | ( Alm, J; Karlsson, A; Skottner, A; Westermark, K, 1988) |
| "Proteinuria decreased during treatment of hyperthyroidism with an antithyroid drug." | ( Akashi, K; Iidaka, K; Inage, Z; Iwamori, M; Kikkawa, Y; Kitagawa, T; Matsuura, M; Serisawa, T; Takimoto, T, 1987) |
| "Chorea resolved with treatment of hyperthyroidism." | ( Ahronheim, JC, 1988) |
| "We use an antithyroid drug for the treatment of hyperthyroidism due to Graves' disease in children and adolescents for as long as the patients are willing to comply and/or tolerate the drug." | ( Kaplan, SA; Landaw, EM; Lippe, BM, 1987) |
| "Upon adequate treatment of the hyperthyroid state the fasting plasma triglyceride concentration was further increased." | ( Kekki, M; Nikkilä, EA, 1972) |
| "In the patients with untreated hyperthyroidism, values for all these functions were greatly increased." | ( Ingbar, SH; Sobel, RJ; Sterling, K; Woeber, KA, 1970) |
| "It is concluded that short-term treatment of hyperthyroid patients with non-selective or selective beta-1-adrenoceptor blocking agents does not impair the glucose stimulated insulin secretion or the carbohydrate tolerance." | ( Kågedal, B; Nilsson, OR; Tegler, L, 1980) |
| "There is extensive experience in the treatment of hyperthyroidism with beta-blockade." | ( Adam, RD; Harrower, AD; Parekh, P, 1981) |
| "In untreated hyperthyroid subjects the plasma cyclic AMP levels were significantly elevated but were normalized when plasma iodothyronine levels declined in the normal range." | ( Baronti, D; Pasargiklian, E; Velardo, A, 1983) |
| "A total of 225 patients were treated for hyperthyroidism with 555 MBq (15 mCi) radioiodine to ablate the thyroid and induce early hypothyroidism." | ( Keir, MJ; Kendall-Taylor, P; Ross, WM, 1984) |
| "Withdrawal of thyroxine treatment from hyperthyroid rats brought back all enzyme activities to normal." | ( Aruldhas, MM; Govindarajulu, P; Valivullah, HM, 1984) |
| "Previous unsuccessful treatments for hyperthyroidism included hemithyroidectomy (2 cats) and an antithyroid drug (7 cats)." | ( Feldman, EC; Hays, M; Hornof, WJ; Turrel, JM, 1984) |
| "Eleven pregnant women were treated for hyperthyroidism with carbimazole (CZ) and one with propylthiouracil (PTU)." | ( Ikonen, E; Lamberg, BA; Osterlund, K; Pekonen, F; Peltola, J; Teramo, K; Välimäki, M, 1984) |
| "The apo B levels were lower in the untreated hyperthyroid patients (86 +/- 23 mg/dl) compared to those in controls (103 +/- 19 mg/dl; P less than 0." | ( Blaton, V; De Moor, P; Lamberigts, G; Lesaffre, E; Muls, E; Rosseneu, M, 1982) |
| "Serum TBPA levels in patients with untreated hyperthyroidism were 12." | ( Hachiya, T; Ijichi, H; Ishida, M; Kajita, Y; Miyazaki, T; Ochi, Y; Yoshimura, M, 1982) |
| "In patients being treated for either hyperthyroidism or hypothyroidism, the serum TSH level appeared to be a sensitive indicator of thyroid status, and its return to normal appeared to be a useful therapeutic criterion." | ( Nisula, BC; Pugeat, MM; Rubenstein, HA; Wehmann, RE, 1983) |
| "In patients with untreated hyperthyroidism, aldosterone response was similar to that in normal subjects." | ( Ieiri, T; Kasai, K; Naitoh, T; Nakamura, T; Shimoda, S; Shina, H; Suzuki, H; Takemura, Y, 1980) |
| "In untreated hyperthyroidism, there was a decreased sensitivity to the antilipolytic effect of insulin, since the dose-response curve was shifted to the right; 250 microU/ml insulin were required for 50% of the maximal effect compared to 25 microU/ml in the controls." | ( Arner, P; Ostman, J; Wennlund, A, 1981) |
| "In the treated hyperthyroid group, organification is not detectable, due to suppressive treatment by thionamides." | ( Greenfield, MA; Harpen, MD; Lee, WP; Siegel, JA; Verma, RC, 1982) |
| "Following treatment of hyperthyroidism by surgery, antithyroid drugs or radioiodine, there was a significant rise in the plasma propranolol Css in patients receiving propranolol either 160 mg/day, 240 mg/day, or 480 mg/day." | ( Crooks, J; Feely, J; Stevenson, IH, 1981) |
| "In addition, apomorphine-treated hyperthyroid animals marched in a row with straub tail, and displayed increased aggressiveness and bizarre social behavior consisting of "mock fighting" when left in pairs." | ( Lapierre, YD; Rastogi, RB; Singhal, RL, 1981) |
| "In untreated hypo- and hyperthyroid subjects, all of the lipid values differed significantly from those of the controls but promptly returned to normal values upon treatment." | ( Abe, SY; Bhagavan, NV; Oshiro, TH; Scottolini, AG, 1980) |
| "The values of Mb in untreated hyperthyroidism were significantly lower (P<0." | ( Kasai, K; Shimoda, SI, 1980) |
| "Atenolol treatment of hyperthyroid rats attenuated the increases in heart rate (HR), rectal temperature, and O2 consumption but did not alter cardiac hypertrophy, hypertension, decreased positive inotropic responses or increased beta-adrenoceptor density." | ( Amos, G; Brown, L; Kerr, D; Sernia, C, 1994) |
| "Untreated or poorly treated hyperthyroidism may present a clinical picture similar to preeclampsia." | ( Baucom, D; Mayer, DC; Spielman, FJ; Thorp, J, 1995) |
| "The SHBG and CBG concentrations in treated hypo- and hyperthyroid patients were not significantly different from those of euthyroid controls." | ( Bennet, AP; Caron, PJ; Dumoulin, SC; Perret, BP, 1995) |
| "Sixteen patients with untreated hyperthyroidism due to Graves' disease (8 female and 8 male), with a mean age (+/- SE) of 31." | ( Ciccarelli, E; Grottoli, S; Portioli, I; Razzore, P; Valcavi, R; Zini, M, 1994) |
| "31 untreated hyperthyroid patients and 12 normal subjects of matched control group were studied." | ( Beldzik, A; Gasińska, T; Nowak, S; Wawrzyniak, L, 1994) |
| "We studied 19 subjects with untreated hyperthyroidism, 12 hyperthyroid subjects sampled at 4-week intervals after beginning carbimazole, 153 subjects receiving T4 replacement, and 300 hospital in-patients with a variety of NTIs." | ( Betteridge, J; Black, EG; Franklyn, JA; Sheppard, MC, 1994) |
| "Our results demonstrate that 131I treatment for hyperthyroidism may seriously damage thyroid C-cells and cause calcitonin deficiency." | ( Georgiadis, G; Nikou, A; Philokiprou, D; Thalassinos, NC; Tzanela, M, 1993) |
| "A woman treated for hyperthyroidism is described." | ( Bergmann, P; Karmali, R; Mirkine, N, 1993) |
| "In 10 newly diagnosed untreated hyperthyroid patients with Graves' disease, we analyzed power spectral density of heart rate cyclic variations at rest, while lying, and while standing." | ( Bellavere, F; Cacciatori, V; Castello, R; Dellera, A; Gemma, ML; Moghetti, P; Muggeo, M; Pezzarossa, A; Thomaseth, K, 1996) |
| "In conclusion, surgically treated former hyperthyroid patients have normal bone mass, bone turnover, and calcium homeostasis in spite of minor variations in thyroid hormones and vitamin D metabolites." | ( Charles, P; Eriksen, EF; Langdahl, BL; Loft, AG; Mosekilde, L, 1996) |
| "Propylthiouracil is widely used in the treatment of hyperthyroidism." | ( Akyol, G; Alkim, H; Boztepe, U; Cakir, N; Kandílć, U; Ozenírler, S; Tuncer, C, 1996) |
| "Thirty cats with untreated hyperthyroidism were blood sampled and their calcium homeostatic mechanisms and renal function assessed." | ( Barber, PJ; Elliott, J, 1996) |
| "In contrast, treatment of hyperthyroidism was associated with an increase in total and HDL cholesterol, and apo AI." | ( Hay, ID; Hodge, D; Katz, K; Kottke, BA; Nguyen, TT; O'Brien, T, 1997) |
| "Chronic triiodothyronine (T3) treatment (hyperthyroidism) increased the interscapular BAT pad weight, its triacylglycerol content, and its DNA content." | ( Kuroshima, A; Ohinata, H; Ohno, T; Saha, SK, 1998) |
| "As adjunctive COL treatment in hyperthyroidism allows reducing MMI dosage it may decrease the rate of dose dependent MMI side effects." | ( Hagag, P; Nissenbaum, H; Weiss, M, 1998) |
| "In untreated hyperthyroid subjects plasma leptin was unrelated to free T3, and in untreated hypothyroidism plasma leptin was unrelated to either free T3 or TSH concentrations (all P = NS)." | ( Coppack, SW; Goodrick, SJ; Johnson, AB; Katz, J; Lightman, SL; Mohamed-Ali, V; Pinkney, JH, 1998) |
| "We conclude that weight gain following treatment of hyperthyroidism is due to 1) reduction in metabolic rate consequent upon the decreased thyroid hormone concentrations and 2) food energy intake which was initially greater than required to maintain individuals' premorbid weight." | ( Abid, M; Billington, CJ; Nuttall, FQ, 1999) |
| "Whenever beta-blockers are chosen for treatment of hyperthyroidism, propranolol (beta 1 + beta 2) has an advantage because it reduces the metabolic rate, whereas selective beta 1-blockade seemed to provide only symptomatic relief, related to the normalization of heart rate." | ( Jansson, S; Körner, U; Lie-Karlsen, K; Lundholm, K; Stenqvist, O; Tisell, LE, 2001) |
| "917 cats with untreated hyperthyroidism, 221 cats with nonthyroidal disease, and 172 clinically normal cats." | ( Melián, C; Nichols, R; Peterson, ME, 2001) |
| "In patients with untreated hyperthyroidism, a significant shortening of PEP, PEPI, LVET and low PEP/LVET index and TPRI as well as increased LVSF, LVEF, mVcf, CIx, CI, OPI and DP were shown." | ( Jonderko, G; Kucharz, EJ; Marcisz, C; Wojewódka, J, 2001) |
| "Surgery seems to be the radical treatment when hyperthyroidism doesn't respond to the medical treatment and when the cardiopathy requires amiodarone." | ( Carlioz, R; Chollet, O; Dariel, MP; Gouteyron, JF; Hervé, S; Leyral, H; Perrier, E, 2001) |
| "A patient with a properly treated hyperthyroidism can safely undergo dental treatment, although periods of stress are to be avoided." | ( Asscheman, H; Gortzak, RA, 1996) |
| "Information from the history (previous treatment for hyperthyroidism, age), physical examination (sex, body weight), routine plasma biochemical analyses (creatinine, cholesterol, potassium, sodium, chloride, and calcium concentrations), and thyroid status were evaluated as potential risk factors for systolic hypertension." | ( Barber, PJ; Elliott, J; Markwell, PJ; Syme, HM, 2002) |
| "We conclude that the treatment of hyperthyroid lactating mothers with doses of 20-30 mg MMI day does not cause deleterious effects on thyroid function of their breast-fed infants." | ( Azizi, F; Hedayati, M, 2002) |
| "Establishment of radioiodine treatment of feline hyperthyroidism in veterinary routine in accordance with German radiation protection regulations." | ( Bauer, R; Grünbaum, EG; Knietsch, M; Puille, M; Spillmann, T, 2002) |
| "A proper, first-line treatment of hyperthyroidism will prevent the deterioration of primary hyperparathyroidism course, and thus surgical parathyroid treatment may safely be introduced." | ( Bednarek, J; Bolko, P; Jaskuła, M; Sowiński, J; Waśko, R, 2003) |
| "Two-thirds of patients with treated hyperthyroidism died." | ( Bernard, W; Feldkamp, J; Horster, FA; Kovács, G; Radácsi, A; Szabolcs, I, 2003) |
| "Percutaneous heat ablation as a treatment for hyperthyroidism in cats is effective transiently but not permanently." | ( Feldman, EC; Hornof, WJ; Mallery, KF; Nelson, RW; Pollard, RE, 2003) |
| "One hundred and one patients with untreated hyperthyroidism were randomly divided into two sex and age-matched groups: group A (n = 45, consuming pure salt without iodine) and group B (n = 56, consuming iodated salt)." | ( Dai, WX; Li, SH; Li, SM; Li, XW; Lian, XL; Lu, L, 2003) |
| "Twenty-two untreated hyperthyroid patients and 17 healthy controls were recruited for the study." | ( Bobby, Z; Chandra Koner, B; Kumar Das, A; Mohan Kumar, KM; Ramesh, R; Ranganathan, P; Selvaraj, N; Sen, SK, 2004) |
| "A 35-year-old Asian male, treated for hyperthyroidism, systemic lupus erythematosis, and uremia presented with low serum total thyroxine (T4) and normal serum thyrotropin (TSH) levels." | ( Kaptein, EM; Nelson, JC; Wilcox, RB, 2004) |
| "Patients with subclinical and treated overt hyperthyroidism have an excess vascular mortality rate." | ( Chowdhary, S; Daykin, J; Franklyn, JA; Gammage, MD; Holder, RL; Osman, F; Sheppard, MC, 2004) |
| "While ISI increased after treatment in the hyperthyroid group (P < 0." | ( Akalin, S; Aydin, H; Deyneli, O; Ozen, Y; Yavuz, DG; Yüksel, M, 2004) |
| "Long-term continuous treatment of hyperthyroidism with MMI is safe." | ( Ataie, L; Azizi, F; Hedayati, M; Mehrabi, Y; Sheikholeslami, F, 2005) |
| "Radioiodine is an effective and safe treatment for hyperthyroidism but has been implicated as a risk factor for deterioration or new presentation of Graves' ophthalmopathy (GO)." | ( Dickinson, J; Frewin, S; Kendall-Taylor, P; Neoh, C; Perros, P, 2005) |
| "This supports treating hyperthyroidism with doses of radioiodine sufficient to induce overt hypothyroidism." | ( Franklyn, JA; Maisonneuve, P; Sheppard, MC, 2005) |
| "Verapamil treatment of hyperthyroid rats completely prevented the increased diastolic stiffness and systolic blood pressure while attenuating the increased body temperature and left ventricular weight; collagen content remained unchanged." | ( Brown, L; Fenning, A; Levick, S, 2005) |
| "Lycopus extract was tested in thyroxine treated hyperthyroid rats (0." | ( Baumgartner, A; Biller, A; Hegger, M; Korte, B; Vonhoff, C; Winterhoff, H, 2006) |
| "Forty-five patients were treated for active hyperthyroidism, 161 were euthyroid (85 immediately before withdrawal of antithyroid drug at maintenance doses, 76 in stable remission after withdrawal of antithyroid treatment)." | ( Baldini, M; Bonfanti, MT; Cantalamessa, L; Castagnone, D; Orsatti, A, 2005) |
| "Radioiodine used for the treatment of hyperthyroidism improved the symptoms of myasthenia gravis in the first patient." | ( Abid, M; Charfi, N; Mhiri, Ch; Mnif, M; Rekik, N; Trabelsi, L; Triki, Ch, 2006) |
| "Discontinuation of methimazole and treatment of hyperthyroidism with lithium followed by radioactive iodine therapy resulted in resolution of his symptoms." | ( Babu, A; Majeed, M, 2006) |
| "KD has good efficacy in treating hyperthyroidism, and the combined treatment of Chinese and Western medicine shows obvious advantages." | ( Fan, J; Yang, HJ; Zheng, M, 2006) |
| "Radioiodine-131 is commonly used for treatment of hyperthyroidism but there are few available data on the effects of this treatment on male gonadal function." | ( Battisti, P; Caglieresi, C; Canale, D; Ceccarelli, C; Fiore, E; Grasso, L; Moschini, C; Pinchera, A; Vitti, P, 2006) |
| "It has proved efficacy in the treatment ofhyperthyroidism, porphyria, cirrhosis, migraine and in the therapy of many neuropsychiatric disorders." | ( Olakowska, E; Olakowski, M, 2006) |
| "Propylthiouracil is a drug used in the treatment of hyperthyroidism for more than 60 years." | ( Atilgan, KG; Ayli, MD; Dede, F; Duranay, M; Guler, S; Memis, L; Yuksel, A; Yuksel, C, 2007) |
| "Forty-five pretreated hyperthyroid patients (mean age 36." | ( Chen, ST; Chen, WJ; Ho, WJ; Hsu, TS; Kuo, CT; Tsay, PK; Wang, CL, 2007) |
| "Among the pretreatment hyperthyroid cohort a lower stiffness was found when the muscle was relaxed (2." | ( An, KN; Bensamoun, SF; Brennan, M; Chen, Q; Ehman, RL; Ringleb, SI, 2007) |
| "Melatonin treatment during hyperthyroidism normalized aconitate hydratase activity and citrate concentration." | ( Pashkov, AN; Popov, SS; Popova, TN; Rakhmanova, TI; Semenikhina, AV; Zoloedov, VI, 2007) |
| "We hypothesized that treatment of hyperthyroidism may have different effects on glomerular and tubular function and these changes might be predicted by additional pre-treatment variables than GFR." | ( Binst, D; Croubels, S; Daminet, S; Kooistra, H; Lefebvre, HP; Meyer, E; Peremans, K; Saunders, JH; van Hoek, I; Vandermeulen, E, 2009) |
| "A decrease in resting heart rate in untreated hyperthyroidism due to verapamil treatment did not result in decreasing N-terminal-pro-B-type natriuretic peptide levels." | ( Andersen, HU; Corell, P; Faber, J; Jarlov, A; Kistorp, C; Schultz, M, 2009) |
| "After adequately treating the hyperthyroidism, basal cortisol levels in both patients returned to the reference range." | ( Burman, KD; Cole, J; Golding, J; Karl, M; Onumah, BM; Wartofsky, L, 2009) |
| "These studies demonstrate that untreated hyperthyroidism is associated with elevated CgA level that changes in parallel to thyroid status." | ( Al-Shoumer, KA; Vasanthy, BA, 2009) |
| "The pretreatment logUI in hyperthyroid cats was compared with that in euthyroid cats, taking into account the effects of renal function on UI concentration." | ( Brodbelt, D; Elliott, J; Petrie, A; Syme, HM; Wakeling, J, 2009) |
| "Thirty patients with untreated hyperthyroidism and 25 age- and sex-matched healthy controls were included in the study." | ( Erem, C; Ersoz, HO; Kocak, M; Nuhoglu, İ; Ucuncu, O; Yilmaz, M, 2009) |
| "The aim of treating hyperthyroidism in pregnancy with antithyroid drugs is to maintain serum thyroxine (T(4)) in the upper normal range of the assay used with the lowest possible dose of drug, whereas in hypothyroidism, the goal is to return serum thyroid-stimulating hormone (TSH) to the range between 0." | ( Davies, TF; Galofre, JC, 2009) |
| "Our protocol effectively treated hyperthyroidism and significantly reduced the hypothyroidism rate." | ( Chen, DY; Chen, TH; He, ZM; Jing, J; Schneider, PF; Zhang, XS, 2011) |
| "Lithium pre-treatment in hyperthyroid patients with low baseline uptake of radioiodine can increase iodine retention in the thyroid gland independently of the primary disease and permits the use of lower doses of radiation in the therapy." | ( Bąk, M; Królicki, L; Płazińska, MT, 2011) |
| "Anti-thyroid drugs (ATD) used to treat hyperthyroidism can cause agranulocytosis." | ( Dybowska, D; Halota, W; Karwowska, K; Kozielewicz, D, 2012) |
| "A 28-year-old woman with PTU-treated hyperthyroidism presented with fever, purpura, pulmonary cavitations and ANCA to myeloperoxidase, bactericidal/permeability-increasing protein (BPI), proteinase-3 and elastase." | ( Bonaci-Nikolic, B; Kontic, M; Nikolic, M; Radovanovic, S, 2012) |
| "GD patients with untreated hyperthyroidism had higher CXCL9 or CXCL11 than hyperthyroid or euthyroid GD patients under methimazole (MMI) treatment." | ( Antonelli, A; Corrado, A; Fallahi, P; Ferrannini, E; Ferrari, SM, 2013) |
| "A total of 30 untreated overt hyperthyroidism patients, 17 euthyroid congenital hypothyroidism children, and age- and sex-matched controls were enrolled." | ( Bai, F; Cheng, JP; Jin, Y; Ma, SG; Xu, W; Yue, HN, 2013) |
| "The recognition and treatment of fetal hyperthyroidism are believed to be important to optimize growth and intellectual development in affected fetuses." | ( Ikenoue, S; Ishii, T; Kadohira, I; Kasuga, Y; Matsumoto, T; Minegishi, K; Miyakoshi, K; Momotani, N; Saisho, Y; Sato, S; Yoshimura, Y, 2013) |
| "After appropriate pharmacologic treatment of her hyperthyroidism, she had complete resolution of her cardiomyopathy." | ( Perkins, MJ; Schachter, DT, 2014) |
| "Nearly 80% of responders do not treat subclinical hyperthyroidism in pregnancy." | ( Akamizu, T; Alamdari, S; Amouzegar, A; Azizi, F; Mehran, L; Poppe, K; San Luis, T; Sarvghadi, F; Subekti, I; Vaidya, B, 2014) |
| "Eprotirome treatment, but not hyperthyroidism, reduced plasma triglycerides." | ( Angelin, B; Bonde, Y; Breuer, O; Lütjohann, D; Rudling, M; Sjöberg, S, 2014) |
| "The treatment of THPP consists of treating for hyperthyroidism plus propranolol." | ( Eustatia-Rutten, CF; Kelderman, N; Kwak, AR; Piekaar, RS, 2014) |
| "After treatment of fetal hyperthyroidism through oral maternal administration of methimazole (MMI) starting at 33 weeks gestation, fetal heart rate and amniotic fluid volume returned to normal ranges." | ( Hayashi, S; Ishii, K; Mitsuda, N; Murata, M; Sasahara, J; Sato, Y, 2014) |
| "Propylthiouracil is a drug used to treat hyperthyroidism." | ( Costa, T; Ferreira, C; Marques, AV, 2015) |
| "Maternal treatments of hyperthyroidism include antithyroid medications such as methimazole and more commonly propylthiouracil (PTU)." | ( Curtis, J; Evans, MI; Felig, P; Kessler, AA; Munoz, JL, 2016) |
| "In control and levothyroxine-treated hyperthyroid rats, an intraperitoneal glucose tolerance test was performed, and the insulin secretion and content of the isolated islets were assayed." | ( Hoshmandi, E; Karbalaei, N; Noorafshan, A, 2016) |
| "Melatonin treatment to hyperthyroidic group lead to decreased TBARS level with a concomitant increase in antioxidant enzyme activity." | ( Agrawal, NK; Haldar, C; Mukherjee, A; Rao, G; Verma, R, 2016) |
| "Premethimazole treatment, eight hyperthyroid cats received CT scans from the head to heart, which were compared to CT of seven euthyroid cats." | ( Bobe, G; Bush, JL; Gordon, J; Nemanic, S, 2017) |
| "Mortality rates for treated and untreated hyperthyroid subjects compared with euthyroid controls were calculated using multivariate Cox regression analyses, controlling for age, sex, and comorbidities." | ( Abrahamsen, B; Brix, TH; Hegedüs, L; Jørgensen, HL; Lillevang-Johansen, M, 2017) |
| "Patients managed on ATDs for the treatment of hyperthyroidism should be counseled to report a pregnancy as early as possible." | ( Andersen, SL, 2017) |
| "Scl-Ab and ZOL treatment of hyperthyroid mice increased trabecular bone volume at the spine by threefold and twofold, respectively." | ( Hofbauer, LC; Klaushofer, K; Köhrle, J; Lademann, F; Misof, BM; Ominsky, MS; Rauner, M; Rijntjes, E; Roschger, P; Tsourdi, E, 2017) |
| "Seventy untreated hyperthyroid patients with GD." | ( Diana, T; Kahaly, GJ; König, J; Riedl, M; Schomburg, L, 2017) |
| "After the initiation of MMI treatment, the hyperthyroid state moves towards subclinical hyperthyroidism and then euthyroidism." | ( Antonelli, A; Benvenga, S; Di Bari, F; Merrill, SJ; Pandiyan, B, 2018) |
| "Low-dose radioiodine is effective treatment for hyperthyroidism in most cats but overt hypothyroidism may develop in some." | ( Finch, NC; Hibbert, A; Stallwood, J; Tasker, S, 2019) |
| "The oral treatment of feline hyperthyroidism with antithyroid drugs often results in gastrointestinal side effects (10-20%)." | ( Böhm, D; Haag, R; Kloner, L; Kohn, B; Moré, M; Moré, S; Volkmann, M, 2020) |
| "Radioiodine (RAI) treatment for hyperthyroidism is a very common modality, chosen by physicians worldwide." | ( Budlewski, T; Franek, E; Gryn, T; Kałuża, B; Stachura, A, 2020) |
| "Options for treatment of hyperthyroidism include: antithyroid drugs, radioactive iodine therapy (the preferred treatment of hyperthyroidism among US thyroid specialists), or thyroidectomy." | ( Barczyński, M, 2021) |
| "We aimed to determine whether treatment of hyperthyroid patients affects the levels of these oxidative stress markers." | ( Bonnema, SJ; Brix, TH; Ellervik, C; Hegedüs, L; Larsen, CB; Larsen, EL; Poulsen, HE; Riis, KR; Winther, KH, 2021) |
| "We described a successful treatment of hyperthyroidism patient with dietary-herbal supplementation with wet cupping without any medicine." | ( Al-Shorman, A; Alhilo, I; Alhilo, S; Alkhatib, B, 2021) |
| "Cats being treated for hyperthyroidism had lower hair iodine." | ( Alborough, R; Gardner, DS; Graham, PA, 2022) |
| "Early detection and treatment of hyperthyroidism, which can further elevate the risk of both of these diseases is therefore required." | ( Frank-Raue, K; Raue, F, 2023) |
| "Clinicians treating hyperthyroid patients should be aware that patients appear much less hyperthyroid from FT4-measurements performed using Alinity compared to Cobas or Centaur." | ( Aas, FE; Dahl, SR; Dahll, LK; Kelp, O; Thorsby, PM; Westbye, AB; Zykova, SN, 2023) |